Telix Pharma withdraws IPO citing market conditions (NYSE:TFX)
pattichaya Telix Pharmaceuticals (New York Stock Exchange:TFX), an Australian company focused on radiopharmaceuticals, decided on Friday to withdraw its plans ...
pattichaya Telix Pharmaceuticals (New York Stock Exchange:TFX), an Australian company focused on radiopharmaceuticals, decided on Friday to withdraw its plans ...
Andrii Yalanskyi Weight loss drug maker Novo Nordisk (NVO) and American healthcare giant Johnson & Johnson (New York Stock Exchange:JNJ) ...
Nerthuz/iStock via Getty Images Phathom Pharmaceuticals (NASDAQ:FAT), rhythm pharmaceuticals (NASDAQ:RYTM), and Vaxcyte (NASDAQ:PCVX) are the most likely targets in the ...
NISIT RAWO/iStock via Getty Images Pharma and biotech deal values rose 35% in 2023, as major drugmakers face patent cliffs ...
Zolak/iStock via Getty Images Vertex Pharmaceuticals (NASDAQ:VRTX) fell ~4%marking the second straight session of losses after Leerink Partners flagged concerns ...
Nadzeya Haroshka Leading pharmaceutical lobbying group PhRMA and drug brokers known as pharmacy benefit managers (PBMs) have resumed their long-running ...
© Reuters By Davit Kirakosyan Investing.com -- Among the biggest deal dispatches of the past week, Sun Pharmaceutical said it ...
Nastassia Samal Biopharmaceutical company Albireo Pharma (NASDAQ: WHITE) as a reaction to its agreement to be acquired by the French ...